Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius

<b>Introduction.</b> <i>Melissococcus plutonius</i> is the causative agent of European foulbrood (EFB), a disease of honey bees that is endemic in many areas of the USA. Only one antibiotic, oxytetracycline (OTC), is approved for EFB management, and there have been reports of recalcitrance.<b>Gap Statement.</b> Resistant strains of <i>M. plutonius</i> have been identified in Canada and Japan, but methodology differs between studies, making reliable comparisons difficult. Additionally, no <i>M. plutonius</i> isolates from the USA have yet been tested for susceptibility to OTC, despite decades of use.<b>Aim.</b> Here, we determine the impact of media, time and persistence on the results of commonly used growth and antibiotic resistance assays using regionally representative <i>M. plutonius</i> isolates.<b>Methodology.</b> Twelve genetically diverse isolates of <i>M. plutonius</i> were tested for susceptibility to OTC using previously published assays, but with variations in media and time to determine factors that may be impacting results.<b>Results.</b> Media composition and incubation time dramatically impact antibiotic susceptibility assays for <i>M. plutonius</i>, differing widely between strains, likely due to differences in OTC stability. Assays that ended when growth appeared on antibiotic-free agar showed that all strains remained susceptible to OTC with an MIC of 2-4 µg ml<sup>-1</sup>. However, <i>M. plutonius</i> remains viable after OTC efficacy wanes, with some strains able to persist at room temperature for at least 3.5 years.<b>Conclusion.</b> To standardize antibiotic susceptibility testing for <i>M. plutonius,</i> we recommend the use of M110 media due to stability and speed of growth. However, all strains of <i>M. plutonius</i> persist on M110 beyond the window of OTC efficacy, complicating assay results and interpretation, and additional research is needed to determine the clinical implications of these findings.

Authors

Institutions

Publication Details

Journal
Journal of Medical Microbiology
Published
2025-12-12
DOI
https://doi.org/10.1099/jmm.0.002109
Primary Topic
Insect and Pesticide Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius

Peter D. Fowler, Meghan O. Milbrath, Robert J. Hawley
Journal of Medical Microbiology
Insect and Pesticide Research
article

Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius

Peter D. Fowler, Meghan O. Milbrath, Robert J. Hawley
article en

Abstract

<b>Introduction.</b> <i>Melissococcus plutonius</i> is the causative agent of European foulbrood (EFB), a disease of honey bees that is endemic in many areas of the USA. Only one antibiotic, oxytetracycline (OTC), is approved for EFB management, and there have been reports of recalcitrance.<b>Gap Statement.</b> Resistant strains of <i>M. plutonius</i> have been identified in Canada and Japan, but methodology differs between studies, making reliable comparisons difficult. Additionally, no <i>M. plutonius</i> isolates from the USA have yet been tested for susceptibility to OTC, despite decades of use.<b>Aim.</b> Here, we determine the impact of media, time and persistence on the results of commonly used growth and antibiotic resistance assays using regionally representative <i>M. plutonius</i> isolates.<b>Methodology.</b> Twelve genetically diverse isolates of <i>M. plutonius</i> were tested for susceptibility to OTC using previously published assays, but with variations in media and time to determine factors that may be impacting results.<b>Results.</b> Media composition and incubation time dramatically impact antibiotic susceptibility assays for <i>M. plutonius</i>, differing widely between strains, likely due to differences in OTC stability. Assays that ended when growth appeared on antibiotic-free agar showed that all strains remained susceptible to OTC with an MIC of 2-4 µg ml<sup>-1</sup>. However, <i>M. plutonius</i> remains viable after OTC efficacy wanes, with some strains able to persist at room temperature for at least 3.5 years.<b>Conclusion.</b> To standardize antibiotic susceptibility testing for <i>M. plutonius,</i> we recommend the use of M110 media due to stability and speed of growth. However, all strains of <i>M. plutonius</i> persist on M110 beyond the window of OTC efficacy, complicating assay results and interpretation, and additional research is needed to determine the clinical implications of these findings.

Journal of Medical MicrobiologyVol. 74(12)
Michigan State University (US)
North Central SARE
Openalex Percentile: Top 64%
Insect and Pesticide Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.